Skip to main content
Fig. 7 | Journal of Inflammation

Fig. 7

From: Expression and clinical significance of the NEK7-NLRP3 inflammasome signaling pathway in patients with systemic lupus erythematosus

Fig. 7

mRNA and protein levels of NEK7, NLRP3 inflammasome components, and downstream cytokines in patients with systemic lupus erythematosus (SLE) after treatment (continuous methylprednisolone treatment; 40 mg/day for two weeks); mRNA levels (a) protein levels (b) and typical western blotting results (c). SLE+BT: SLE patients before treatment; SLE+AT: SLE patients after treatment. *p < 0.05,**p < 0.01, ***p < 0.0001

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us